Alturas Analytics, Inc. is pleased to announce the opening of a 2,200 square foot expansion dedicated to Sample Management. This site serves for the receipt, management, and storage of all study samples.
We understand that address...
As we look back on 2020, I am struck by the power of collaboration. So many across industries have come together to address the global pandemic unlike any time we’ve seen before. It is with deep gratitude that we acknowledge and...
ALTURAS ANALYTICS IN 2020
The year 2020 has brought unprecedented events and a heightened urgency. For Alturas Analytics it is also the celebration of our 20th year of business success, through a focused emphasis on scientific...
Effective July 16, 2019, Alturas Analytics is thrilled to announce the appointment of Dr. Lori Payne to the Business Development team as Executive Director of Business Development joining Ann Hoffman, VP Strategic Development.
"Dr....
“Pharmacokinetic studies are a critical component in evaluating the safety and efficacy of a drug from discovery through post-marketing clinical trials.” Sara Underwood spent 16 years in the biotechnology industry performing...
The 58th Annual Meeting and ToxExpo
Society of Toxicology
March 10-14, Baltimore, MD
Baltimore Convention Center
We look forward to seeing you in Baltimore for a week of innovation and the impact that emerging technologies has...
A Message from Robin Woods, Alturas Analytics President
As the sun sets on a successful 2018, and we open 2019 feeling invigorated and are poised for another growth year at Alturas, we would like to thank our partners for your continued...
A Message From Robin Woods, President
At Alturas Analytics, 2016 was the year for building infrastructure and preparing for growth to meet new challenges. With investments in capital equipment, scientific staff, a facility expansion,...
